UPC Analytics
ENDE
Overview · Filed: —

UPC_APP_24411/2025

System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Procedural & sub-applicationsSettlement HomologationCourt of AppealApplication Rop 365—Settled at: Post-appeal
OverviewDecisionsCitationsDocumentsTimeline
Parties

Claimants

  • Tandem Diabetes Care Europe B.V.
  • Tandem Diabetes Care, Inc.
Reps: Christian Dekoninck (Taylor Wessing); null (AOMB)

Respondents

Reps: Christof Augenstein (Kather Augenstein); null (Grünecker Patent- und Rechtsanwälte)
Judges
  • Rian KaldenPresiding judge and legally qualified judge
  • Ingeborg SimonssonLegally qualified judge and judge-rapporteur
  • Patricia RombachLegally qualified judge
  • Jeroen MeewisseTechnically qualified judge
  • Stefan WilhelmTechnically qualified judge
Patents
  • EP2196231
CPC codes: A61M2209/045, A61M5/148, A61M5/14244

Sector: Pharmaceutical & Medical

Outcome
Settled
Filed: —
First decided: Jun 5, 2025
Language: —
Settled at: Post-appeal — settled commercially

The Court of Appeal confirmed a settlement agreement between Tandem Diabetes and Roche Diabetes, terminating the appeal proceedings. The settlement arose after the Central Division Paris had dismissed the revocation action and maintained EP 2 196 231 as granted.